These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4148915)

  • 21. The effect of 6-hydroxydopamine on the antinociceptive action of morphine.
    Slater P; Blundell C
    Eur J Pharmacol; 1978 Apr; 48(3):237-47. PubMed ID: 639852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcellular and perisynaptic distribution of rat brain aldehyde dehydrogenase activity.
    Koivula T; Turner AJ; Huttunen M; Koivusalo M
    J Neurochem; 1981 Jun; 36(6):1893-7. PubMed ID: 6113270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central catecholaminergic lesions in the developing rat: effects of cardiac noradrenaline levels, turnover and release.
    Deskin R; Slotkin TA
    J Auton Pharmacol; 1981 Jun; 1(3):205-10. PubMed ID: 7338526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural and biochemical changes in rat cerebral cortex after neonatal 6-hydroxydopamine administration.
    Onténiente B; König N; Sievers J; Jenner S; Klemm HP; Marty R
    Anat Embryol (Berl); 1980; 159(3):245-55. PubMed ID: 7457904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the effects of chemical sympathectomy by 6-hydroxydopamine in newborn and adult rats.
    Finch L; Haeusler G; Thoenen H
    Br J Pharmacol; 1973 Feb; 47(2):249-60. PubMed ID: 4146573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melatonin attenuates methamphetamine-induced reduction of tyrosine hydroxylase, synaptophysin and growth-associated protein-43 levels in the neonatal rat brain.
    Kaewsuk S; Sae-ung K; Phansuwan-Pujito P; Govitrapong P
    Neurochem Int; 2009 Nov; 55(6):397-405. PubMed ID: 19409439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of adrenal catecholamines and their synthesizing enzymes during ontogenesis and aging in rats.
    Kvetnanský R; Jahnová E; Torda T; Strbák V; Baláz V; Macho L
    Mech Ageing Dev; 1978 Mar; 7(3):209-16. PubMed ID: 23469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood dopamine beta-hydroxylase activity and noradrenaline levels in the developing white rat.
    Behrens WA; Lacelle S; Depocas F
    Can J Physiol Pharmacol; 1979 Apr; 57(4):380-4. PubMed ID: 455137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noradrenaline contents of hypothalamus and adrenal gland increased by postnatal administration of 6-hydroxydopamine.
    Lew GM; Quay WB
    Res Commun Chem Pathol Pharmacol; 1971 Nov; 2(6):807-12. PubMed ID: 5170594
    [No Abstract]   [Full Text] [Related]  

  • 30. Brain catecholamines metabolism in offspring of amphetamine treated rats.
    Nasello AG; Ramirez OA
    Pharmacol Biochem Behav; 1978 Jul; 9(1):17-20. PubMed ID: 30095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for the role of adrenocortical hormones in the regulation of noradrenaline and dopamine metabolism in certain brain areas.
    Rastogi RB; Singhal RL
    Br J Pharmacol; 1978 Jan; 62(1):131-6. PubMed ID: 23193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catecholamine concentrations and the activity of tyrosine hydroxylase after an increase in the concentration of tyrosine in rat tissues.
    Dairman W
    Br J Pharmacol; 1972 Feb; 44(2):307-10. PubMed ID: 4148919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of a permanent and selective depletion of brain catecholamines on the antinociceptive action of morphine.
    Slater P; Blundell C
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Dec; 305(3):227-32. PubMed ID: 740050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early behavioral and catecholaminergic effects of 6-hydroxydopamine and guanethidine in the neonatal rat.
    Pappas BA; Peters DA; Sobrian AK; Blouin A; Drew B
    Pharmacol Biochem Behav; 1975; 3(4):681-5. PubMed ID: 242015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenaline, noradrenaline and dopamine levels in brain and heart after administration of 6-hydroxydopamine and guanethedine to newborn mice.
    Liuzzi A; Foppen FH; Angeletti PU
    Biochem Pharmacol; 1974 Mar; 23(6):1041-4. PubMed ID: 4824904
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of selective destruction of central and peripheral catecholamine-containing neurones with 6-hydroxydopamine on catecholamine excretion in the rat.
    Hoeldtke R; Rogawski M; Wurtman RJ
    Br J Pharmacol; 1974 Feb; 50(2):265-70. PubMed ID: 4425765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Operant behavioural and neurochemical effects after neonatal 6-hydroxydopamine treatment.
    Peterson DW; Laverty R
    Psychopharmacology (Berl); 1976 Oct; 50(1):55-60. PubMed ID: 13445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of central and peripheral catecholaminergic systems in rats addicted perinatally to methadone.
    Lau C; Bartolomé M; Slotkin TA
    Neuropharmacology; 1977; 16(7-8):473-8. PubMed ID: 21355
    [No Abstract]   [Full Text] [Related]  

  • 40. Reserpine effect on the axonal transport of dopamine-beta-hydroxylase and tyrosine hydroxylase in rat brain.
    Levin BE
    Exp Neurol; 1981 Apr; 72(1):99-112. PubMed ID: 6162666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.